Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1758-9193
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration ; volume:14 ; number:1 ; day:13 ; month:10 ; year:2022 ; pages:1-12 ; date:12.2022
Alzheimer's research & therapy ; 14, Heft 1 (13.10.2022), 1-12, 12.2022

Creator
Benussi, Alberto
Cantoni, Valentina
Rivolta, Jasmine
Archetti, Silvana
Micheli, Anna
Ashton, Nicholas
Zetterberg, Henrik
Blennow, Kaj
Borroni, Barbara
Contributor
SpringerLink (Online service)

DOI
10.1186/s13195-022-01094-5
URN
urn:nbn:de:101:1-2022123021090990085644
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:33 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Benussi, Alberto
  • Cantoni, Valentina
  • Rivolta, Jasmine
  • Archetti, Silvana
  • Micheli, Anna
  • Ashton, Nicholas
  • Zetterberg, Henrik
  • Blennow, Kaj
  • Borroni, Barbara
  • SpringerLink (Online service)

Other Objects (12)

White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer’s disease

White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer’s disease

Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer’s Disease from Frontotemporal Lobar Degeneration

Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer’s Disease from Frontotemporal Lobar Degeneration

Plasma biomarkers increase diagnostic confidence in patients with Alzheimer’s disease or frontotemporal lobar degeneration

Plasma biomarkers increase diagnostic confidence in patients with Alzheimer’s disease or frontotemporal lobar degeneration

Mitochondrial DNA haplogroups in early-onset Alzheimer's disease and frontotemporal lobar degeneration

Mitochondrial DNA haplogroups in early-onset Alzheimer's disease and frontotemporal lobar degeneration

CSF neurogranin levels as a biomarker in Alzheimer’s disease and frontotemporal lobar degeneration: a cross-sectional analysis

CSF neurogranin levels as a biomarker in Alzheimer’s disease and frontotemporal lobar degeneration: a cross-sectional analysis

Blood-based molecular biomarkers for Alzheimer’s disease

Blood-based molecular biomarkers for Alzheimer’s disease

Delusions in frontotemporal lobar degeneration

Delusions in frontotemporal lobar degeneration

Blood‐based biomarkers for Alzheimer's disease

Blood‐based biomarkers for Alzheimer's disease

YKL-40 changes are not detected in post-mortem brain of patients with Alzheimer’s disease and frontotemporal lobar degeneration

YKL-40 changes are not detected in post-mortem brain of patients with Alzheimer’s disease and frontotemporal lobar degeneration

Presenilins in Alzheimer’s disease and frontotemporal dementia

Presenilins in Alzheimer’s disease and frontotemporal dementia

Blood-based biomarkers and plasma Aβ assays in the differential diagnosis of Alzheimer’s disease and behavioral-variant frontotemporal dementia

Blood-based biomarkers and plasma Aβ assays in the differential diagnosis of Alzheimer’s disease and behavioral-variant frontotemporal dementia

Frontotemporal Lobar Degeneration: A Clinical Approach

Frontotemporal Lobar Degeneration: A Clinical Approach

Related objects